Advertisement

Evidence for Mononuclear Phagocytes in Solid Neoplasms and Appraisal of Their Nonspecific Cytotoxic Capabilities

  • Stephen W. Russell
  • G. Yancey Gillespie
  • Judith L. Pace
Part of the Contemporary Topics in Immunobiology book series (CTI, volume 10)

Abstract

After years of being viewed as little more than scavengers, mononuclear phagocytes are now more properly regarded as cells with a multiplicity of functions. One of these, tumor cell killing, recently has attracted particular interest. Both antigenically specific and nonspecific effects have been reported (for reviews, see Evans and Alexander, 1976; Hibbs, 1976; and Keller, 1976). Of the two, nonspecific killing has been the most extensively studied, with a number of candidates for the cytolytic mechanism(s) now under consideration (Hibbs, 1974a; Bucana, et al.,1976; Ferluga, et al., 1978; Schorlemmer, et al., 1978; Currie, 1978; Adams, 1978). The process is nonphagocytic in its nature, either contact or extremely close juxtaposition of the target and effector cells is required, and only tumor cells appear to be susceptible to killing.

Keywords

Mononuclear Phagocyte Cytolytic Activity Tumor Target Cell Macrophage Content Tumor Tissue Section 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abraham, R., and Barbolt, T. A., 1978, Lysosomal enzymes in macrophages of colonic tumors induced in rats by 1,2-dimethylhydrazine dihydrochloride, Cancer Res. 38: 2763–2767.PubMedGoogle Scholar
  2. Adams, D. 0., 1978, Culture supernatants of activated macrophages (AM) selectively lyse neoplastic cells, J. Reticuloendothel. Soc. 24: 21a.Google Scholar
  3. Alexander, P., and Evans, R., 1971, Endotoxin and double stranded RNA render macrophages cytotoxic, Nature (London) New Biol. 232: 76–78.Google Scholar
  4. Alexander, P., Eccles, S. A., and Gauci, C. L. L., 1976, The significance of macrophages in human and experimental tumours, Ann. N.Y. Acad. Sci. 276: 124–133.PubMedCrossRefGoogle Scholar
  5. Birbeck, M. S. C., and Carter, R. L., 1972, Observations on the ultrastructure of two hamster lymphomas with particular reference to infiltrating macrophages, Int. J. Cancer 9: 249–257.PubMedCrossRefGoogle Scholar
  6. Bordin, S., and Young, E. T., 1976, Tumor-associated macrophages as the primary source of lysozyme in the urine of mice bearing GPC-11, a transplantable reticulum cell sarcoma, J. Natl. Cancer Inst. 57: 827–835.PubMedGoogle Scholar
  7. Bucana, C., Hoyer, L. C., Hobbs, B., Breesman, S., McDaniel, M., and Hanna, M. G., 1976, Morphological evidence for the translocation of lysosomal organelles from cytotoxic macrophages into the cytoplasm of tumor target cells, Cancer Res. 36: 4444–4458.PubMedGoogle Scholar
  8. Carr, I., and Underwood, J. C. E., 1974, The ultrastructure of the local cellular reaction to neoplasia, Int. Rev. Cytol. 37: 329–347.PubMedCrossRefGoogle Scholar
  9. Cohen, D., Gurner, B. W., and Coombs, R. R. A., 1971, A phenomenon resembling opsonic adherence shown by disaggregated cells of the transmissible venereal tumour of the dog, Br. J. Exp. Pathol. 52: 447–451.Google Scholar
  10. Currie, G. A., 1978, Activated macrophages kill tumour cells by releasing arginase, Nature (London) 273: 758–759.CrossRefGoogle Scholar
  11. Currie, G. A., and Basham, C., 1975, Activated macrophages release a factor which lyses malignant cells but not normal cells, J. Exp. Med. 142: 1600–1605.PubMedCrossRefGoogle Scholar
  12. Currie, G. A., and Eccles, S. A., 1976, Serum lysozyme as a marker of host resistance. I. Production by macrophages resident in rat sarcomata, Br. J. Cancer 33: 51–59.PubMedCrossRefGoogle Scholar
  13. Doe, W. F., and Henson, P. M., 1978, Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells, J. Exp. Med. 148: 544–556.PubMedCrossRefGoogle Scholar
  14. Eccles, S. A., and Alexander, P., 1974a, Macrophage content of tumours in relation to metastatic spread and host immune reaction, Nature (London) 250: 667–669.CrossRefGoogle Scholar
  15. Eccles, S. A., and Alexander, P., 1974b, Sequestration of macrophages in growing tumours and its effect on the immunological capacity of the host, Br. J. Cancer 30: 42–49.PubMedCrossRefGoogle Scholar
  16. Edelson, R. L., Smith, R. W., Frank, M. M., and Green, I., 1973, Identification of sub-populations of mononuclear cells in cutaneous infiltrates. I. Differentiation between B cells, T cells and histiocytes. J. Invest. Dermatol. 61: 82–89.PubMedCrossRefGoogle Scholar
  17. Edelson, R. L., Hearing, V. J., Dellon, A. L., Frank, M., Edelson, E. K., and Green, I., 1975, Differentiation between B cells, T cells and histiocytes in melanocytic lesions: Primary and metastic melanoma and halo and giant pigmented nevi, Clin. Immunol. Immunopathol. 4: 557–568.PubMedCrossRefGoogle Scholar
  18. Elston, C. W., 1968, Cellular reaction to choriocarcinoma, J. Pathol. 97: 261–268.CrossRefGoogle Scholar
  19. Evans, R., 1972, Macrophages in syngeneic animal tumours, Transplantation 14:468–473. Evans, R., 1973a, Macrophages and the tumour bearing host, Br. J. Cancer 28 (Suppl. I): 19–25.Google Scholar
  20. Evans, R., 1973b, Preparation of pure cultures of tumor macrophages, J. Natl. Cancer Inst. 50: 271–273.PubMedGoogle Scholar
  21. Evans, R., 1975, Macrophage-mediated cytotoxicity: Its possible role in rheumatoid arthritis, Ann. N.Y. Acad. Sci. 256: 275–287.PubMedCrossRefGoogle Scholar
  22. Evans, R., 1976, Tumor macrophages in host immunity to malignancies, in: The Macro-phages in Neoplasia ( M. Fink, ed.), pp. 27–42, Academic Press, New York.Google Scholar
  23. Evans, R., 1977, Effect of X-irradiation on host-cell infiltration and growth of a murine fibrosarcoma, Br. J. Cancer 35: 557–566.PubMedCrossRefGoogle Scholar
  24. Evans, R., 1979, Host cells in transplanted murine tumors and their possible relevance to tumor growth, J. Reticuloendothel. Soc. 26: 427–437.PubMedGoogle Scholar
  25. Evans, R., and Alexander, P., 1976, Mechanisms of extracellular killing of nucleated mammalian cells by macrophages, in: Immunobiology of the Macrophage ( D. S. Nelson, ed.), pp. 535–576, Academic Press, New York.Google Scholar
  26. Evans, R., and Booth, C. G., 1976, Inhibition of 125IUdR incorporation by supernatants from macrophages and lymphocyte cultures: A cautionary note, Cell. Immunol. 26: 120–126.PubMedCrossRefGoogle Scholar
  27. Ferluga, J., Schorlemmer, H. U., Baptista, L. C., and Allison, A. C., 1978, Production of the complement cleavage product, C3a, by activated macrophages and its tumorolytic effects, Clin. Exp. Immunol. 31: 512–517.PubMedGoogle Scholar
  28. Gauci, C. L., 1976, The significance of the macrophage content of human tumours, in: Recent Results in Cancer Research, Vol. 56 ( G. Mathé, I. Florentin, and M. -C. Simmler, eds.), pp. 122–130, Springer-Verlag, New York.Google Scholar
  29. Gebhardt, M. C., and Fisher, B., 1979, Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. IX. Macrophage content of tumors in mice,/ Natl. Cancer Inst. 62: 1035–1041.Google Scholar
  30. Gillespie, G. Y., and Russell, S. W., 1978, Development and persistence of cytolytic T lymphocytes in regressing or progressing Moloney sarcomas, Int. J. Cancer 21: 94–99.PubMedCrossRefGoogle Scholar
  31. Gillespie, G. Y., Hansen, C. B., and Russell, S. W., 1978, Resurgence of killing and in vivo protection mediated by lymphocytes cultured from lymph nodes draining Moloney sarcomas, Br. J. Cancer 38: 365–374.PubMedCrossRefGoogle Scholar
  32. Gordon, S., Todd, J., and Cohn, Z. A., 1974, In vitro synthesis and secretion of lysozyme by mononuclear phagocytes, J. Exp. Med. 139: 1228–1248.Google Scholar
  33. Haskill, J. S., Proctor, J. W., and Yamamura, Y., 1975a, Host responses within solid tumors. I. Monocytic effector cells within rat sarcomas, J. Natl. Cancer Inst. 54: 387–393.PubMedGoogle Scholar
  34. Haskill, J. S., Yamamura, Y., and Radov, L., 1975b, Host responses within solid tumors: Nonthymus-derived specific cytotoxic cells within a murine mammary adenocarcinoma, Int. J. Cancer 16: 798–809.PubMedCrossRefGoogle Scholar
  35. Haskill, J. S., Radov, L. A., Yamamura, Y., Parthenais, E., Korn, J. H., and Ritter, F. L., 1976, Isolation and identification of specific and non-specific effector cells in experimental solid tumors, J. Reticuloendothel. Soc. 20: 233–241.PubMedGoogle Scholar
  36. Haskill, S., and Parthenais, E., 1978, Immunologic factors influencing the intratumor localization of ADCC effector cells, J. Immunol. 120: 1813–1817.PubMedGoogle Scholar
  37. Hibbs, J. B., 1974, Heterocytolysis by macrophage activated by bacillus Calmette-Guérin: Lysosome exocytosis into tumor cells, Science 184: 468–471.PubMedCrossRefGoogle Scholar
  38. Hibbs, J. B., 1976, The macrophage as a tumoricidal effector cell: A review of in vivo and in vitro studies on the mechanism of the activated macrophage nonspecific cytotoxic reaction, in: The Macrophage in Neoplasia ( M. Fink, ed.), pp. 83–111, Academic Press, New York.Google Scholar
  39. Hibbs, J. B., Taintor, R. R., Chapman, H. A., and Weinberg, J. B., 1977, Macrophage tumor killing: Influence of the local environment, Science 197: 279–282.PubMedCrossRefGoogle Scholar
  40. Holden, H. T., Haskill, J. S., Kirchner, H., and Herberman, R. B., 1976, Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors, J. Immunol. 117: 440–446.PubMedGoogle Scholar
  41. Humphrey, L. J., Milgrom, F., Tqlnder, O., and Witebsky, E., 1967, Hemadsorption by murine tumors, Fed. Proc. 26: 702.Google Scholar
  42. Keller, R., 1976, Cytostatic and cytocidal effects of activated macrophages, in: Immuno-biology of the Macrophage (D. S. Nelson, ed.), pp. 487–508, Academic Press, New York. Kerbel, R. S., and Davies, A. J. S., 1974, The possible biological significance of Fc receptors on mammalian lymphocytes and tumor cells, Cell 3:105–112.Google Scholar
  43. Kerbel, R. S., Pross, H. F., and Elliott, E. V., 1975, Origin and partial characterization of Fc receptor-bearing cells found within experimental carcinomas and sarcomas, Int. J. Cancer 15: 918–932.PubMedCrossRefGoogle Scholar
  44. Kerbel, R. S., Pross, H. F., and Leibovitz, A., 1977, Analysis of established human carcinoma cell lines for lymphoreticular-associated membrane receptors, Int. J. Cancer 20: 673679.Google Scholar
  45. Korn, J. H., Haskill, J. S., Holden, H. T., Radov, L. A., and Ritter, F. L., 1978a, In situ FcGoogle Scholar
  46. receptor-bearing cells in two murine tumors. I. Isolation and identification, J. Natl. Cancer Inst. 60: 1387–1390.Google Scholar
  47. Korn, J. H., Haskill, J. S., Holden, H. T., Rodov, L. A., and Ritter, F. L., 1978b, In situ Fc receptor-bearing cells in two murine tumors. II. Role in tumor immunity, J. Natl. Cancer Inst. 60: 1391–1397.PubMedGoogle Scholar
  48. Lantos, P. L., 1975, Macrophages in brain tumours induced transplacentally by N-ethyl-N-nitrosourcea in rats: An electron-microscope study, J. Pathol. 116: 107–115.PubMedCrossRefGoogle Scholar
  49. Lauder, I., Aherne, W., Stewart, J., and Sainsbury, R., 1977, Macrophage infiltration of breast tumours: A prospective study, J. Clin. Pathol. 30: 563–568.PubMedCrossRefGoogle Scholar
  50. Long, D. M., Multer, F. K., Greenburg, A. G., Peskin, G. W., Lasser, E. C., Wickham, W. G., and Shuts, C. M., 1978, Tumor imaging with x-rays using macrophage uptake of radiopaque fluorocarbon emulsions, Surgery 84: 104–112.PubMedGoogle Scholar
  51. Mantovani, A., 1978, Effects on in vitro tumor growth of murine macrophages isolated from sarcoma lines differing in immunogenicity and metastasizing capacity, Int. J. Cancer 22: 741–746.PubMedCrossRefGoogle Scholar
  52. Martin, F., Martin, M., Jeannin, J. -F., and Lagneau, A., 1978, Rat macrophage-mediated toxicity to cancer cells: Effect of endotoxins and endotoxin inhibitors contained in culture media, Eur. J. Immunol. 8: 607–611.PubMedCrossRefGoogle Scholar
  53. Matre, R., 1976, Specificity of Fey receptors in human malignant tissue and normal lymphoreticular tissue, Scand. J. Immunol. 5: 963–968.PubMedCrossRefGoogle Scholar
  54. Matre, R., Tinder, O., Thunold, S., and Solhaug, J. H., 1976, Properties of Fcy receptors in normal and malignant human tissues, Scand. J. Immunol. 5: 361–368.PubMedCrossRefGoogle Scholar
  55. Mendiondo, O., Suit, H., and Fixler, H., 1978, Lysozyme levels and macrophage content of tumor tissue in CH3 mice bearing fibrosarcoma transplants treated by radiation and Corynebacterium parvum, Int. J. Radiat. Biol. 4: 829–834.CrossRefGoogle Scholar
  56. Milgrom, F., Humphrey, L. J., Tinder, O., Yasuda, J., and Witebsky, E., 1968, Antibody-mediated hemadsorption by tumor tissues, Int. Arch. Allergy Appl. Immunol. 33: 478–492.PubMedCrossRefGoogle Scholar
  57. Monis, B., and Weinberg, T., 1961, Cytochemical study of esterase activity of human neoplasms and stromal macrophages, Cancer 14: 369–377.PubMedCrossRefGoogle Scholar
  58. Moore, K., and Moore, M., 1977a, Intra-tumour host cells of transplanted rat neoplasms of different immunogenicity, Int. J. Cancer 19: 803–813.PubMedCrossRefGoogle Scholar
  59. Moore, M., and Moore, K., 1977b, Kinetics of macrophage infiltration of experimental rat neoplasms, in: The Macrophage and Cancer ( K. James, B. McBride, and A. Stuart, eds.), pp. 330–339, Department of Surgery, University of Edinburgh Medical School, Scotland.Google Scholar
  60. Morantz, R. A., Wood, G. W., Foster, M., Clark, M., and Gollahon, K., 1979a, Macrophages in experimental and human brain tumors. Part 1: Studies of the macrophage content of experimental rat brain tumors of varying immunogenicity, J. Neurosurg. 50: 298–304.PubMedCrossRefGoogle Scholar
  61. Morantz, R. A., Wood, G. W., Foster, M., Clark, M., and Gollahon, K., 1979b, Macrophages in experimental and human brain tumors. Part 2: Studies of the macrophage content of human brain tumors, J. Neurosurg. 50: 305–311.PubMedCrossRefGoogle Scholar
  62. Normann, S. J., and Cornelius, J., 1978, Concurrent depression of tumor macrophage infiltration and systemic inflammation by progressive cancer growth, Cancer Res. 38: 3453–3459.PubMedGoogle Scholar
  63. Opitz, H. -G., Niethammer, D., Jackson, R. C., Lemke, H., Huget, R., and Flad, H. -D., 1975, Biochemical characterization of a factor released by macrophages, Cell. Immunol. 18: 70–75.PubMedCrossRefGoogle Scholar
  64. Owen, J. J. T., and Seeger, R. C., 1973, Immunity to tumours of the murine leukaemia-sarcoma virus complex, Br. J. Cancer 28 (Suppi. 1): 26–34.Google Scholar
  65. Perri, G. C., Cappuccino, J. G., Faulk, M., Mellors, J., and Stock, C. C., 1963, Variations of the content of lysozyme in normal rats and in rats bearing Jensen sarcoma following surgery, Cancer Res. 23: 431–435.PubMedGoogle Scholar
  66. Pross, H. F., and Kerbel, R. S., 1976, An assessment of intratumor phagocytic and surface marker-bearing cells in a series of autochthonous and early passaged chemically induced murine sarcomas, J. Natl. Cancer Inst. 57: 1157–1167.PubMedGoogle Scholar
  67. Puccetti, P., and Holden, H. T., 1979, Cytolytic and cytostatic anti-tumor activities of macrophages from mice injected with murine sarcoma virus, Int. J. Cancer 23: 123–133.PubMedCrossRefGoogle Scholar
  68. Rosenau, W., and Moon, H. D., 1966, Cellular reactions to methylcholanthrene-induced sarcomas transplanted to isogenic mice, Lab. Invest. 15: 1212–1224.PubMedGoogle Scholar
  69. Ruco, L. P., and Meltzer, M. S., 1978, Macrophage activation for tumor cytotoxicity: Development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions. J. Immunol. 121: 2035–2042.PubMedGoogle Scholar
  70. Russell, S. W., and McIntosh, A. T., 1977, Macrophages isolated from regressing Moloney sarcomas are more cytotoxic than those recovered from progressing sarcomas, Nature (London) 268: 69–71.CrossRefGoogle Scholar
  71. Russell, S. W., Doe, W. F., and Cochrane, C. G., 1976a, Number of macrophages and distribution of mitotic activity in regressing and progressing Moloney sarcomas, J. Immunol. 116: 164–166.Google Scholar
  72. Russell, S. W., Doe, W. F., Hoskins, R. G., and Cochrane, C. G., 1976b, Inflammatory cells in solid murine neoplasms. I. Tumor disaggregation and identification of constituent inflammatory cells, Int. J. Cancer 18: 322–330.PubMedCrossRefGoogle Scholar
  73. Russell, S. W., Gillespie, G. Y., Hansen, C. B., and Cochrane, C. G., 1976c, Inflammatory cells in solid murine neoplasms. II. Cell types found throughout the course of Moloney sarcoma regression or progression, Int. J. Cancer 18: 331–338.PubMedCrossRefGoogle Scholar
  74. Russell, S. W., Doe, W. F., and McIntosh, A. T., 1977a, Functional characterization of a stable, noncytolytic stage of macrophage activation in tumors, J. Exp. Med. 146: 1511–1520.PubMedCrossRefGoogle Scholar
  75. Russell, S. W., Gillespie, G. Y., and McIntosh, A. T., 1977b, Inflammatory cells in solid murine neoplasms. III. Cytotoxicity mediated in vitro by macrophages recovered from disaggregated regressing Moloney sarcomas, J. Immunol. 118: 1574–1579.PubMedGoogle Scholar
  76. Schorlemmer, H. U., Hadding, U., Bitter-Suerman, D., and Allison, A. C., 1978, The role of complement cleavage products in killing of tumour cells by macrophages, in: The Macrophage and Cancer ( K. James, B. McBride, and A. Stuart, eds.), pp. 68–77, Department of Surgery, University of Edinburgh Medical School, Scotland.Google Scholar
  77. Shevach, E. M., Jaffe, E. S., and Green, I., 1973, Receptors for complement and immunoglobulin on human and animal lymphoid cells, Transplant. Rev. 16: 3–28.PubMedGoogle Scholar
  78. Snodgrass, M. J., and Hanna, M. G., Jr., 1973, Ultrastructural studies of histiocyte-tumor cell interactions during tumor regression after intralesional injection of Mycobacterium bovis, Cancer Res. 33: 701–716.PubMedGoogle Scholar
  79. Stadecker, M. J., Calderon, J., Karnovsky, M. L., and Unanue, E. R., 1977, Synthesis and release of thymidine by macrophages, J. Immunol. 119: 1738–1743.PubMedGoogle Scholar
  80. Stewart, C. C., and Beetham, K. L., 1978, Cytocidal activity and proliferative ability of macrophages infiltrating the EMT6 tumor, Int. J. Cancer 22: 152–159.PubMedCrossRefGoogle Scholar
  81. Stewart, C. C., Adles, C., and Hibbs, J. B., 1977, Interaction of macrophages with tumor cells, in: The Reticuloendothelial System in Health and Disease ( H. Friedman and M. R. Escobar, eds.), pp. 423–433, Plenum Press, New York.Google Scholar
  82. Stutman, 0., 1975, Delayed tumour appearance and absence of regression in nude mice infected with murine sarcoma virus, Nature (London) 253: 142–144.CrossRefGoogle Scholar
  83. Szymaniec, S., and James, K., 1976, Studies on the Fc receptor bearing cells in a trans- planted methylcholanthrene induced mouse fibrosarcoma, Br. J. Cancer 33: 36–49.PubMedCrossRefGoogle Scholar
  84. Taniyama, T., and Holden, H. T., 1979, Cytolytic activity of macrophages isolated from primary murine sarcoma virus (MSV)-induced tumors, Int. J. Cancer 24: 151–160.PubMedCrossRefGoogle Scholar
  85. Targowski, S. P., Abeyounis, C. J., and Milgrom, F., 1977a, Studies on adsorption by tumor tissue of erythrocytes sensitized by IgG antibodies, Int. Arch. Allergy Appl. Immunol. 54: 262–268.PubMedCrossRefGoogle Scholar
  86. Targowski, S. P., Abeyounis, C. J., and Milgrom, F., 1977b, Effect of murine tumor sera on adsorption of IgG-sensitized erythrocytes by rnurine sarcoma tissue, Proc. Soc. Exp. BioL Med. 154: 365–367.PubMedGoogle Scholar
  87. TSnder, O., and Thunold, S., 1973, Receptors for immunoglobulin Fc in human malignant tissues, Scand. J. Immunol. 2: 207–215.CrossRefGoogle Scholar
  88. TOnder, O., Milgrom, F., and Witebsky, E., 1964, Mixed aggultination with tissue sections, J. Exp. Med. 119: 265–274.CrossRefGoogle Scholar
  89. Milder, O., Morse, P. A., and Humphrey, L. J., 1974, Similarities of Fc receptors in human malignant and normal lymphoid tissue, J. Immunol. 113: 1162–1169.Google Scholar
  90. TOnder, O., Humphrey, L. J., and Morse, P. A., 1975, Further observations on Fc receptors in human malignant tissue and normal lymphoid tissue, Cancer 35: 580–587.PubMedCrossRefGoogle Scholar
  91. TOnder, O., Krishnan, E. C., Jewell, W. R., Morse, P. A., and Humphrey, L. J., 1976, Tumor Fc receptors and tumor-associated immunoglobulin, Acta Pathol. Microbiol. Scand. 84C: 105–111.Google Scholar
  92. Turner, D. T. L., Connolly, C. E., Isaacson, P., and Turnbull, A. R., 1978, Receptors for Fc and complement in human breast carcinoma, Clin. Oncology 4: 87–92.Google Scholar
  93. Underwood, J. C. E., and Carr, I., 1972, The ultrastructure of the lymphoreticular cells in non-lymphoid human neoplasms, Virchows Arch. B. 12: 39–50.Google Scholar
  94. van Loveren, H., and Den Otter, W., 1974, Macrophages in solid tumors. I. Immunologically specific effector cells, J. Natl. Cancer Inst. 53: 1057–1060.PubMedGoogle Scholar
  95. Weinberg, J. B., Chapman, H. A., Jr., and Hibbs, J. B., Jr., 1978, Characterization of the effects of endotoxin on macrophage tumor cell killing, J. Immunol. 121: 72–80.PubMedGoogle Scholar
  96. Wood, G. W., and Gillespie, G. Y., 1975, Studies on the role of macrophages in regulation of growth and metastasis of murine chemically induced fibrosarcomas, Int. J. Cancer 16: 1022–1029.PubMedCrossRefGoogle Scholar
  97. Wood, G. W., and Gollahon, K. A., 1977, Detection and quantitation of macrophage infiltration into primary human tumors with the use of cell-surface markers, J. Natl. Cancer Inst. 59: 1081–1087.PubMedGoogle Scholar
  98. Wood, G. W., and Gollahon, K. A., 1978, T-lymphocytes and macrophages in primary murine fibrosarcomas at different stages in their progression, Cancer Res. 38: 1857–1865.PubMedGoogle Scholar
  99. Wood, G. W., and Morantz, R. A., 1979, Immunohistologic evaluation of the lymphoreticular infiltrate of human central nervous system tumors, J. Natl. Cancer Inst. 62: 485–491.PubMedGoogle Scholar
  100. Wood, G. W., Gillespie, G. Y., and Barth, R. F., 1975, Receptor sites for antigen-antibody complexes on cells derived from solid tumors: Detection by means of antibody sensitized sheep erythrocytes labeled with technetium-99m, J. Immunol. 114: 950–957.PubMedGoogle Scholar
  101. Wood, G. W., Neff, J. R., Gollahon, K. A., and Gourley, W. K., 1978, Macrophages in giant cell tumours of bone, J. Pathol. 125: 53–58.PubMedCrossRefGoogle Scholar
  102. Woods, A. E., and Papadimitriou, J. M., 1977, The effect of inflammatory stimuli on the stroma of neoplasms: The involvement of mononuclear phagocytes, J. Pathol. 123: 163–174.CrossRefGoogle Scholar
  103. Woodward, J. G., and Daynes, R. A., 1978, Cell-mediated immune response to syngeneic UV induced tumors. I. The presence of tumor associated macrophages and their possible role in the in vitro generation of cytotoxic lymphocytes, Cell. Immunol. 41: 304–319.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1980

Authors and Affiliations

  • Stephen W. Russell
    • 1
  • G. Yancey Gillespie
    • 1
  • Judith L. Pace
    • 1
  1. 1.Department of Pathology and The Cancer Research CenterUniversity of North Carolina School of MedicineChapel HillUSA

Personalised recommendations